Skip to content
The Centers for Disease Control and Prevention (CDC) added a recently approved monoclonal antibody (mAb) for respiratory syncytial virus (RSV) prevention to the list […]
CDC recommends routine use of RSV monoclonal antibody for infants Read More »
Merck on July 27 announced positive Phase 3 results for a new pneumococcal conjugate vaccine, which targets several varieties of bacteria that cause pneumococcal pneumonia.
Merck’s pneumococcal vaccine for adults shows promise in Phase 3 trial Read More »
Every 3 seconds, one person worldwide develops dementia. With an estimated 5.9 million Americans living with dementia today, and 44 million people living with
The World Health Organization (WHO) reports that routine vaccination rates among children have increased, although there’s room for improvement. According to UNICEF and WHO
Routine immunization among kids is improving Read More »
Voters hold a favorable opinion of biotechnology and support streamlined government regulatory processes to allow faster approval of biotech innovations in agriculture, according to
Creative individuals are spearheading imaginative approaches as biotech battles cancer, the leading cause of death worldwide. Profiles of leaders from a cancer institute and
Innovators describe biotech advances against cancer in I am BIO videos Read More »
A new antibiotic that could potentially be effective against many superbugs, tuberculosis, and even “untreatable” illnesses has been discovered, reports Nature, using none other
From AI to antibiotics: Can machine learning help us fight superbugs? Read More »
The 340B Program has grown exponentially as hospitals take advantage of the opportunity to profit from drug discounts while the low-income and uninsured patients
BIO tells Senators the 340B program needs reforms so it helps patients Read More »
International partnerships are vital to delivering new biotech solutions for the health of people and the planet—and strong policies, both in the U.S. and
BIO Asia-Taiwan 2023 highlights importance of cross-border collaboration Read More »
Federal support empowers a public-private partnership that helps ensure U.S. leadership in drug development—and the relationship should not be changed by calls for arbitrary
BIO expert lauds beautiful relationship between NIH and biotech Read More »
